β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking
Open Access
- 7 May 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (5) , e0196946
Abstract
A pituitary adenylate cyclase-activating polypeptide (PACAP)-specific receptor, PAC1R, is coupled with multiple signal transduction pathways including stimulation of adenylate cyclase, phospholipase C and extracellular-signal regulated kinase (ERK)1/2. PAC1R has been shown to exert its long-lasting and potent signals via β-arrestin1 and β-arrestin2. However, the precise roles of the two β-arrestin isoforms in PACAP-PAC1R signaling remain unclear. Here we examined the interaction between the two β-arrestin isoforms and PAC1R, β-arrestin-dependent PAC1R subcellular localization and ERK1/2 activation. Upon PACAP stimulation, although PAC1R similarly interacted with β-arrestin1 and β-arrestin2 in HEK293T cells, the complex of PAC1R and β-arrestin2 was translocated from the cell surface into cytosol, but that of β-arrestin1 remained in the cell surface regions in HeLa cells and mouse primary cultured neurons. Silencing of β-arrestin2 blocked PACAP-induced PAC1R internalization and ERK1/2 phosphorylation, but silencing of β-arrestin1 increased ERK1/2 phosphorylation. These results show that β-arrestin1 and β-arrestin2 exert differential actions on PAC1R internalization and PAC1R-dependent ERK1/2 activation, and suggest that the two β-arrestin isoforms may be involved in fine and precise tuning of the PAC1R signaling pathways.Keywords
Funding Information
- JSPS KAKENHI (JP26293020)
- JSPS KAKENHI (JP17H03989)
- JSPS KAKENHI (JP17K19488)
- JSPS KAKENHI (JP16K08269)
- Japan Agency for Medical Research and Development (JP) (JP17dm0107122h0002)
- Japan Agency for Medical Research and Development (JP17dm0207061h0001)
This publication has 44 references indexed in Scilit:
- β-arrestin2 in Infiltrated Macrophages Inhibits Excessive Inflammation after Myocardial InfarctionPLOS ONE, 2013
- Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout miceFrontiers in Behavioral Neuroscience, 2012
- Agonist-directed Interactions with Specific β-Arrestins Determine μ-Opioid Receptor Trafficking, Ubiquitination, and DephosphorylationJournal of Biological Chemistry, 2011
- Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophreniaNature, 2011
- Post-traumatic stress disorder is associated with PACAP and the PAC1 receptorNature, 2011
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- Depression‐like behavior in the forced swimming test in PACAP‐deficient mice: amelioration by the atypical antipsychotic risperidoneJournal of Neurochemistry, 2009
- Pituitary adenylate cyclase-activating polypeptide is associated with schizophreniaMolecular Psychiatry, 2007
- Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6Proceedings of the National Academy of Sciences, 2006
- Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptorsNature Reviews Neuroscience, 2001